切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2014, Vol. 03 ›› Issue (05) : 327 -330. doi: 10.3877/cma.j.issn.2095-3224.2014.05.03

所属专题: 文献

专家论坛

结直肠癌多酚类植物化学预防剂的研究进展
刘明1()   
  1. 1. 150001 哈尔滨医科大学附属第四医院普外一科
  • 收稿日期:2014-09-27 出版日期:2014-10-25
  • 通信作者: 刘明
  • 基金资助:
    国家自然科学基金面上项目(81372612)

The advance of researches on polyphenols as a chemoprophylactic agent for colorectal cancer

Ming LIU1,()   

  1. 1. General Surgery, the Fourth Affiliated Hospital of Harbin Medical University, 150001 Harbin, China
  • Received:2014-09-27 Published:2014-10-25
  • Corresponding author: Ming LIU
  • About author:
    Corresponding author: LIU Ming, Email:
引用本文:

刘明. 结直肠癌多酚类植物化学预防剂的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2014, 03(05): 327-330.

Ming LIU. The advance of researches on polyphenols as a chemoprophylactic agent for colorectal cancer[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2014, 03(05): 327-330.

结直肠癌是世界范围最常见的恶性肿瘤之一,目前的治疗方法预后欠佳。因此化学预防的概念应运而生,其中植物化学预防因其成本低,毒副作用小的优点,近年来受到越来越多的关注。笔者现将讨论结直肠癌植物化学预防剂的研究进展。

Colorectal cancer is one of the most prevalent cancers in many countries, the prognosis of current treatments is not good.Chemoprevention emerges as the time goes by.Among those chemoprevention, plant chemoprevention has became a hot topic, clue to its low cost and its minor side-effect.We will discuss the progress of plant chemoprevention for colorectal tumor in this paper.

图1 鞣花酸结构式示意图
图2 姜黄素结构式示意图
图3 儿茶素-3-没食子酸结构式示意图
图4 白藜芦醇结构式示意图
[1]
Landete JM.Ellagitannins, ellagic acid and their derived metabolites:a review about source, metabolism, functions and health.Food Res Int, 2011, 44: 1150-1160.
[2]
Larrosa M,Garcia-Conesa MT,Espin JC, et al.Ellagitannins, ellagic acid and vascular health.Mol Aspects Med, 2010, 31: 513-539.
[3]
Malik A,Afaq S,Shahid M, et al.Influence of ellagic acid on prostate cancer cell proliferation:a caspase-dependent pathway.Asian Pac J Trop Med, 2011, 4: 550-555.
[4]
Rosillo MA,Sanchez-Hidalgo M,Cárdeno A, et al.Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease.Biochem Pharmacol, 2011, 82: 737-745.
[5]
Honglian Yu,Lijuan Liu.In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T 24 cells.Food and Chemical Toxicology, 2013, 59: 428-437.
[6]
Mishra S,Vinayak M. Ellagic acid induces novel and atypical PKC isoforms and promotes caspase-3 dependent apoptosis by blocking energy metabolism.Nutr Cancer, 2014, 66(4): 675-681.
[7]
Sujatha Ramasamy,Abdul Wahab.Growth inhibition of human gynecologic and colon cancer cells by phyllanthus watsonii through apoptosis induction.PLoS ONE, 2012, 20: 7(4): 34793.
[8]
Juan A,Giméenez-Bastida,Mar Larrosa.Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts.J Agric Food Chem, 2012, 60: 8866-8876.
[9]
Kishor Butte,Munira Momin.Optimisation and in vivo evaluation of pectin based drug delivery system containing curcumin for colon.Int J Biomater, 2014: 924278.
[10]
Das RK,Kasoju N,Bora U. Encapsulation of curcumin in alginate–chitosan–pluronic composite nanoparticles for delivery to cancer cells.Nanomedicine, 2010, 6: 153-160.
[11]
Irving GR,Karmokar A,Berry DP, et al.Curcumin:the potential for efficacy in gastrointestinal diseases.Best Pract Res Clin Gastroenterol, 2011, 25: 519-534.
[12]
Wilken R,Veena MS,Wang MB, et al.Curcumin:A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.Mol Cancer, 2011, 10: 12.
[13]
Vyas A,Dandawate P,Padhye S, et al.Perspectives on new synthetic curcumin analogs and their potential anticancer properties.Curr Pharm Des, 2013, 19(11): 2047-2069.
[14]
Santos S,Bruno M. Nanoencapsulation of polyphenols for protective effect against colon–rectal cancer.Biotechnology Advances, 2013, 31: 514-523.
[15]
Link Alexander,Francesc Balaguer.Curcumin modulates DNA methylation in colorectal cancer cells.PLOS ONE, 2013, 8(2): e57709.
[16]
Radhakrishnan VM,Ramalingam R. pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin:involvement of non-receptor type 1 protein tyrosine phosphatase(PTPN1). PLoS One, 2014, 9(1): 85796.
[17]
Mehdi Shakibaei,Constanze Buhrmann.Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high.Density Cultures, 2014, Jan 3;9(1): e85397.
[18]
Volate SR,Muga SJ,Issa AY, et al.Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer.Molecular carcinogenesis, 2009, 48: 920-933.
[19]
Vondina R,Rebecca W. Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells.Anticancer Res, 2013, 33(12): 5325-5333.
[20]
Fang MZ,Wang Y,Ai N, et al.Tea polyphenol(-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.Cancer research, 2003, 63: 7563-7570.
[21]
Song Yi,Chang Hee.Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression.Oncology Letters, 2013, 6: 1346-1350.
[22]
Stetler-Stevenson WG.Type IV collagenases in tumor invasion and metastasis.Cancer Metastasis Rev, 1990, 9: 289-303.
[23]
Singh BN,Shankar S,Srivastava RK.Green tea catechin, epigallocatechin-3-gallate(EGCG):mechanisms, perspectives and clinical applications.Biochem Pharmacol, 2011, 82: 1807-1821.
[24]
Wang Jinhua,Ding Weijia.Three new resveratrol derivatives from the mangrove endophytic fungus alternariasp.Mar Drugs, 2014, 12: 2840-2850.
[25]
De Maria,Maria Cartenì.Polydatin, a natural precursor of resveratrol, induces cell cycle arrest and differentiation of human colorectal Caco-2 cell.Journal of Translational Medicine, 2013, 11: 264.
[26]
Min-Yu Chung,Gyu Lim,Won Lee.Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development.World J Gastroenterol, 2013, 19(7): 984-993.
[1] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[2] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[3] 谢丽春, 欧庆芬, 张秋萍, 叶升. 简化和标准肝脏MRI方案在结直肠癌肝转移患者随访中的临床应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 434-437.
[4] 施烨鑫, 马翔, 鲁明, 夏青城, 王鹏超, 宋青雨, 赵庆洪. 腹腔镜下结直肠肿瘤定位研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 463-466.
[5] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[6] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[7] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[8] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[9] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[10] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[11] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[12] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[13] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[14] 季鹏程, 鄂一民, 陆晨, 喻春钊. 循环外泌体相关生物标志物在结直肠癌诊断中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 265-273.
[15] 李佳莹, 王旭丹, 梁雪, 张雷, 李佳英. 1990~2021年中国结直肠癌死亡趋势分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 274-279.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?